⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 31, 2012European Respiratory JournalOpen Access

Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

FIGURE 1: Habitus of Minibiotus gumersindoi n. sp., holotype. Scale bar = 50 m.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zumla et al. (2012) studied this question.

synapsesocial.com/papers/6a929a38dc4973d8f73aa502 https://doi.org/10.1183/09031936.00171611

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Preventing and managing antimicrobial resistance: imperative for chest physiciansOriginal Research · 2011 · 25 citations
2Knowledge of tuberculosis-treatment prescription of health workers: a systematic reviewSystematic Review · 2011 · 38 citations
3New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmesHuman Clinical Trial · 2010 · 138 citations
4TB and M/XDR-TB infection control in European TB reference centres: the Achilles’ heel?: Table 1–Original Research · 2011 · 58 citations
5Towards the development of EU/EEA Standards for Tuberculosis Care (ESTC)Original Research · 2011 · 39 citations